Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares Outstanding
Ratios

Mereo BioPharma Group (MREO) Shares Outstanding: 2018-2025

Historic Shares Outstanding for Mereo BioPharma Group (MREO) over the last 3 years, with Sep 2025 value amounting to $795.5 million.

  • Mereo BioPharma Group's Shares Outstanding rose 2.82% to $795.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $795.5 million, marking a year-over-year increase of 2.82%. This contributed to the annual value of $775.7 million for FY2024, which is 10.63% up from last year.
  • As of Q3 2025, Mereo BioPharma Group's Shares Outstanding stood at $795.5 million, which was up 0.06% from $795.0 million recorded in Q2 2025.
  • Mereo BioPharma Group's 5-year Shares Outstanding high stood at $17,774.9 billion for Q2 2023, and its period low was -$209.66 during Q2 2021.
  • Its 3-year average for Shares Outstanding is $1,616.6 billion, with a median of $773.7 million in 2024.
  • Data for Mereo BioPharma Group's Shares Outstanding shows a peak YoY grew of 13.35% (in 2025) over the last 5 years.
  • Quarterly analysis of 4 years shows Mereo BioPharma Group's Shares Outstanding stood at $788.5 million in 2021, then reached $701.2 million in 2023, then grew by 10.63% to $775.7 million in 2024, then grew by 2.82% to $795.5 million in 2025.
  • Its last three reported values are $795.5 million in Q3 2025, $795.0 million for Q2 2025, and $795.0 million during Q1 2025.